Most Read News

The financing will be directed toward housing, land acquisition, and infrastructure projects.

Kenox, a contract drug maker with a focus on inhaled and nasal products, will handle formulation and development, while Strides brings in manufacturing scale and market access.

Execution of the projects is scheduled to begin in December 2025 and continue through March 2026.

The venture will follow a 50:50 shareholding structure, with Morepen Medipath indirectly holding a 30% stake.

The order will be delivered in stages over the next six to ten months and deployed across ACME’s firm and dispatchable renewable energy (FDRE) projects as well as standalone BESS projects

The project is slated for completion in 18–36 months and will require an investment of about ₹250 crore, to be funded through internal accruals and debt, if necessary.

IT stocks continued to see selling pressure. NIFTY BANK witnessed a modest revival as it recovered after 2 consecutive weeks of losses. NIFTY FMCG notched its 3rd consecutive week of gain.

Here are some of the stocks that may see significant price movement today: Infosys, Brigade Enterprises, Strides Pharma, etc.

On Sept 08, 2025, the Indian shares ended marginally higher on Monday

The company’s current order book stands at about ₹1,335 crore, with demand coming from marquee clients across the oil & gas, power, chemicals, and process industries.